Invasive candidiasis in a pediatric tertiary hospital: Epidemiology, antifungal susceptibility, and mortality rates
Medical Mycology · 2024
DOI: 10.1093/mmy/myae097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Mycology, 2024. Verfasst von Luiza Souza Rodrigues und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Paraná, CEP 80230-020, Brazil. Hauptthemen laut MEDLINE: Tertiary Care Centers, Antifungal Agents, Candidiasis, Invasive, Candida. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Invasive infections caused by non-albicans Candida are increasing worldwide. However, there is still a lack of information on invasive candidiasis (IC) in the pediatric setting, including susceptibility profiles and clonal studies. We investigated the clinical, epidemiologic, and laboratory characteristics of IC, possible changes in antifungal susceptibility profiles over time, and the occurrence of clonality in our tertiary children's hospital. We analyzed 123 non-duplicate Candida isolates from sterile sites of pediatric patients in a tertiary hospital in southern Brazil, between 2016 and 2021. Data on demographics, comorbidities, and clinical outcomes were collected. Candida species distribution, antifungal susceptibility profiles, biofilm production, and molecular epidemiology of isolates were assessed using reference methods. The range of IC incidence was 0.88–1.55 cases/1000 hospitalized patients/year, and the IC-related mortality rate was 20.3%. Of the total IC cases, 42.3% were in patients aged < 13 months. Mechanical ventilation, parenteral nutrition, and intensive care unit (ICU) admission were common in this group. In addition, ICU admission was identified as a risk factor for IC-related mortality. The main site of Candida spp. isolation was blood, and non-albicans Candida species were predominant (70.8%). No significant clonal spread was observed among isolates of the three most commonly isolated species, and 99.1% of all isolates were biofilm producers. Non-albicans Candida species were predominant in this study. Notably, clonal expansion and emergence of antifungal drug resistance were not observed in our pediatric setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Paraná, CEP 80230-020, Brazil.
- Faculdades Pequeno Príncipe, Curitiba, Paraná, CEP 80230-020, Brazil.
- Hospital Pequeno Príncipe, Curitiba, Paraná, CEP 80250-060, Brazil.
- Universidade Estadual de Maringá, Departamento de Análises Clínicas e Biomedicina, Maringá, Paraná, CEP 87020-900, Brazil.
- Universidade Federal do Paraná, Departamento de Patologia Básica, Curitiba, Paraná, CEP 81531-980, Brazil.
ORCID-Profile: Luiza Souza Rodrigues
Zitieren
APA
Rodrigues, L. S., Siqueira, A. C., Vasconcelos, T. M., Ferreira, A. M. M., Spalanzani, R. N., Krul, D., Medeiros, É., Sestren, B., Lanzoni, L. A., Ricieri, M. C., Motta, F. A., Estivalet, T. I., & Dalla-Costa, L. M. (2024). Invasive candidiasis in a pediatric tertiary hospital: Epidemiology, antifungal susceptibility, and mortality rates. Medical Mycology. https://doi.org/10.1093/mmy/myae097
Vancouver
Rodrigues LS, Siqueira AC, Vasconcelos TM, Ferreira AMM, Spalanzani RN, Krul D, et al. Invasive candidiasis in a pediatric tertiary hospital: Epidemiology, antifungal susceptibility, and mortality rates. Medical Mycology. 2024. doi:10.1093/mmy/myae097
BibTeX
@article{Rodrigues2024,
author = {Rodrigues, Luiza Souza and Siqueira, Adriele Celine and Vasconcelos, Thaís Muniz and Ferreira, Amanda Maria Martins and Spalanzani, Regiane Nogueira and Krul, Damaris and Medeiros, Érika and Sestren, Bianca and Lanzoni, Laura de Almeida and Ricieri, Marinei Campos and Motta, Fábio Araújo and Estivalet, Terezinha Inez and Dalla-Costa, Libera Maria},
title = {Invasive candidiasis in a pediatric tertiary hospital: Epidemiology, antifungal susceptibility, and mortality rates},
journal = {Medical Mycology},
year = {2024},
doi = {10.1093/mmy/myae097}
}
EUVIMED